MRI AutoDetect

BIOTRONIK Wins Cardiostim Innovation Award

BIOTRONIK has won the Cardiostim Innovation Award in the category “Best Practice Improvement” for its MRI AutoDetect feature. The company’s Ilivia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization device (CRT-Ds) are the world’s first equipped with a sensor capable of automatically recognizing a magnetic resonance imaging (MRI) environment.

BIOTRONIK winner of Cardiostim Award 2016.
BIOTRONIK winner of Cardiostim Award 2016.

MRI AutoDetect allows cardiologists to activate a special window lasting up to 14 days, during which all normal device functionality is maintained until a unique built-in sensor detects the presence of an MRI scanner. Once activated, the sensor automatically detects the MR environment and activates a predefined MRI mode, which necessarily entails limited device therapy. When the patient leaves the MR environment, the device automatically reactivates the permanent program, thus limiting the time in MRI mode to an absolute minimum. Once the scan is complete, all device functionality is restored without the need for the cardiologist’s intervention. Soon after, the cardiologist can receive a full report transmitted via BIOTRONIK Home Monitoring®.

This represents a significant advance over the current situation, in which patients go unprotected by full ICD functionality for longer than the actual scanning procedure lasts. Reducing the amount of time a patient’s ICD and CRT-D spends in MRI mode is particularly crucial, as dangerous arrhythmias requiring defibrillation can strike at any time. With MRI AutoDetect the only time patients do not benefit from full device therapy is during the relatively short time spent in the scanner itself.

“MRI AutoDetect exemplifies the spirit of innovation that thrives at BIOTRONIK,” commented Manuel Ortega, Senior Vice President at BIOTRONIK. “It is a crucial improvement over current standard practice on two counts—it helps improve efficiency and streamline workflows between radiologists and cardiologists, while, most importantly, keeping patients safer by reducing the amount of time their device is in MRI mode. We are honored at this recognition of our steadfast commitment to advancing patient care beyond the implant.”


Source: BIOTRONIK

10.06.2016

Read all latest stories

Related articles

Photo

Biomonitor III

The next generation injectable cardiac monitor

Biotronik announces the market release of its new injectable cardiac monitor (ICM), Biomonitor III, following approval in the CE region. The novel device is designed to help patients with irregular…

Photo

Preview Medical Taiwan 2019

Healthcare exhibition showcases technology from Taiwan

Artificial intelligence clinics and rehab bikes, exoskeletons and stylish protections masks – healthcare in Taiwan has many faces and facets as the international medical & healthcare exhibition…

Photo

First pacemaker with event-triggered IEGM transmissions

Biotronik, a leading manufacturer of cardiovascular medical technology, announced CE approval for its new Eluna pacemaker series. The new generation of pacemakers includes single and dual-chamber as…

Related products

allMRI GmbH – MRI vacuum immobilisation for head coils

Accessories / Complementary systems

allMRI GmbH – MRI vacuum immobilisation for head coils

allMRI GmbH
allMRI GmbH – MRI wheelchair – foldable

Accessories / Complementary systems

allMRI GmbH – MRI wheelchair – foldable

allMRI GmbH
allMRI GmbH – MRI wheeled waste bin – 90 liters

Accessories / Complementary Systems

allMRI GmbH – MRI wheeled waste bin – 90 liters

allMRI GmbH
Block Imaging

3 Tesla

Block Imaging

Block Imaging
Canon – Vantage Elan

1.5 Tesla

Canon – Vantage Elan

Canon Medical Systems Europe B.V.
Canon – Vantage Galan 3 T

3 Tesla

Canon – Vantage Galan 3 T

Canon Medical Systems Europe B.V.